FDA Investigator Maya M Davis

Maya M Davis has conducted inspections on 94 sites in 7 countries as of 19 Sep 2019. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
94
Last Inspection Date:
19 Sep 2019
Investigator Role:
FDA Investigator
Redica ID:
100006816
Countries of Inspections:
United States of America, Germany, United Kingdom of Great Britain and Northern Ireland, Italy, Czechia, Switzerland, Sweden
FDA Investigators that have inspected at least one site in common with Maya M Davis:
Abdur Rafay Shareef, Adetutu M Gidado, Alexander V Gontcharov, Alice C Silva, Alice S Tsao, Amber G Wardwell, Amy C Jordan, Andrea A Branche, Andrew M Barlow, Anthony C Warchut, Anthony N Onianwa, Arie C Menachem, Armen H Youssoufian, Azza Talaat, Betsy C Galliher, Blake C Hamann, Brandy N Lepage, Brenda P King, Brenna L Macdowell, Brinda Dass, Bruce H Mccullough, Byungja E Marciante, Camerson E Moore, Carl A Anderson, Caryn M Mcnab, Cassandra L Abellard, Charles R Cote, RIC, Christina A Miller, Christine H Lee, Christine L Williams, Christine M Whitby, CSO, Christopher Janik, Chunsheng Cai, PhD, Constance Desimone, Corey K Reno, Courtney N Long, Cynthia F Kleppinger, MD, Cynthia J Lee, MS, Daniel L Zheng, Darin S Wiegers, Darla J Christopher, Darren S Brown, Daryl A Dewoskin, David M Beltran, Deborah A Greco, Dennis Cantellops Paite, Diane C Thibodeau, Dien N Nguyen, Donald L Lech, Dr. Jason R Caballero, Edmund F Mrak, Jr, Eduardo L Rodriguez, Edward Deberry, Edward J Janik, Edwin Melendez, Ellen P Madigan, Eric C Schmitt, Erin I Keith, Felix Maldonado, Gabrielle J Swain, Gale E Ryan, Gary J Hagan, George M Ibrahim, George R Smith, Gerard D Difiore, Hang N Guo, Harlan J Howard, Helen B Ricalde, Holly Brevig, Jacob G Lutz, James L Dunnie, Jr, Jamie M Du, Janete F Guardia, Jawaid Hamid, Jeffrey J Thibodeau, Jennifer M Gogley, Joao Pedras Vasconcelos, PhD,, John A Hollings, John J Thibodeau, John L Zaccone, John P Mistler, Jonah S Ufferfilge, Jonathan G Matrisciano, Joseph H Procopio, Jr, Juanita P Versace, Justine M Corson, Katherine D Adams, Katie L Korchinski, Kenneth H Williams, Kent A Conforti, Kevin D Kallander, Kham Phommachanh, Kimberly M White, Kristina J Donohue, Kumar G Janoria, Laura L Staples, Laurie B Frazier, Laurimer Kuilan Torres, LCDR Debra Emerson, LCDR Michael H Tollon, Linda L Green, Linda Thai, Malini Wileman, PhD, Margaret E Walsh, Margaret M Annes, Margaret M Sands, Mark C Lookabaugh, Mark R Mcclain, Martin J Guardia, Marvin D Jones, Mary Jeanet Mcgarry, Maryam Tabatabaie, Matthew C Watson, Maura Rooney, Megan A Haggerty, Meisha A Mandal, Melissa D Ray, Miah Jung, Michael E Maselli, Michael G Mayfield, Michael P Sheehan, Michael R Goga, Michelle M Noe Varga, Michelle Rfrazier Jessen, PhD, Mihaly S Ligmond, Mikayla K Deardorff, Mra B Kamberem, Mra Davism, Mra M Barbosar, Mra Mcculloughj, Mra Munizn, Nancy L Rolli, Nealie C Newberger, Nichole B Murphy, Nina Yang, Ogechi C Nna, Osama A Khatib, Pamela N Agaba, Paraluman S Leonin, Parul M Patel, Paul E Stein, Paul L Bellamy, Paul Lihong Yeh, PhD, Paula M Laplant, Peter R Lenahan, Philip F Istafanos, DMV, MS, Philip Kreiter, Phillip E Mclaughlin, Raeann R Wu, Rafael Nevarez Nieves, Ralph A Erickson, Ramon E Martinez, Rapti D Madurawe, Rebecca B Welch, Rebecca E Dombrowski, Richard H Penta, Robert D Tollefsen, Robert J Martin, Robert O'brian, Rochelle K Kimmel, Rory K Geyer, Roy R Rinc, Russell K Riley, Saied A Asbagh, Samantha J Bradley, Samir C Gala, Sangeeta M Khurana, PhD, Sean R Marcsisin, Sharon K Gershon, Sharon K Thoma, PharmD, Sherri N Rohlf, MD, Simone E Pitts, Stacey S Degarmo, Stephanie Mangigian, MS/OSH, RN, Stephen C Smith, Stephen D Brown, Stephen R Souza, Steven D Kehoe, Steven P Donald, Susan M Jackson, Susanne M Richardson, MS RAC, Suzanne M Healy, Tanya R Syffrard, Terri L Dodds, Thomas J Arista, Thomas W Nerney, Thuy T Nguyen, LCDR, Tiara Nbrown Crosen, Timothy T Kapsala, Todd D Alspach, Tomika L Crafter, Towanda L Terrell, Tyanna N Hadley, Valentino Fiorella, Victoria M Daddeo, Wayne E Seifert, Xiaojun Yan, Xiaoping Guan, Yvins Dezan, Zachary A Bogorad

Maya M Davis's Documents

Publish Date Document Type Title
January, 2015 EIR AIRGAS USA, LLC - EIR, 2015-01-14
September, 2012 FDA 483 Aplicare Products, LLC - Form 483, 2012-09-06
September, 2011 FDA 483 Teva Czech Industries s.r.o - Form 483, 2011-09-22
March, 2015 FDA 483 Sheffield Pharmaceuticals LLC - Form 483, 2015-03-19
October, 2010 FDA 483 R.S.A. Corp. - Form 483, 2010-10-25
February, 2012 EIR Pfizer Laboratories Div Pfizer Inc - EIR, 2012-02-24
September, 2019 FDA 483 Glaxo Operations UK Ltd - Form 483, 2019-09-17
March, 2012 FDA 483 Exemplar Pharmaceuticals LLC - Form 483, 2012-03-21
January, 2015 FDA 483 Pfizer Laboratories Div Pfizer Inc - Form 483, 2015-01-23
January, 2012 FDA 483 Exemplar Pharmaceuticals LLC - Form 483, 2012-01-13
June, 2013 FDA 483 Tower Laboratories Ltd - Form 483, 2013-06-18
March, 2014 FDA 483 CooperSurgical, Inc. - Form 483, 2014-03-10
September, 2019 FDA 483 Fisiopharma SRL - Form 483, 2019-09-27
May, 2013 FDA 483 Mannkind Corporation - Form 483, 2013-05-17
January, 2015 EIR Pfizer Laboratories Div Pfizer Inc - EIR, 2015-01-23
November, 2010 FDA 483 Prostar Inc. - Form 483, 2010-11-17
April, 2015 FDA 483 Brookfield Medical/Surgical Supplies, Inc. - Form 483, 2015-04-09
December, 2010 FDA 483 Obagi Medical Products - Form 483, 2010-12-09
September, 2011 FDA 483 Novartis Pharma Produktions GmbH - Form 483, 2011-09-15
December, 2009 FDA 483 Mannkind Corporation - Form 483, 2009-12-04
February, 2013 FDA 483 Central Admixture Pharmacy Services, Inc. - Form 483, 2013-02-19
September, 2014 FDA 483 Alexion Pharmaceuticals, Inc. - Form 483, 2014-09-26
February, 2015 EIR Alexion Pharma LLC - EIR, 2015-02-19
May, 2012 FDA 483 Purdue Pharma L.P. - Form 483, 2012-05-25
May, 2015 FDA 483 Cardinal Health 414, LLC - Form 483, 2015-05-08
August, 2013 FDA 483 Pharmagen Laboratories, Inc - Form 483, 2013-08-23
September, 2010 FDA 483 RHG & Company Inc. - Form 483, 2010-09-02
November, 2012 FDA 483 I-Health, Inc. - Form 483, 2012-11-28
December, 2013 FDA 483 Braintree Laboratories, Inc. - Form 483, 2013-12-13
March, 2012 FDA 483 Tower Laboratories Ltd - Form 483, 2012-03-15
November, 2010 FDA 483 Ultimate Nutrition, Inc. - Form 483, 2010-11-17
September, 2013 FDA 483 Avista Pharma Solutions, Inc. dba Cambrex - Form 483, 2013-11-13
January, 2015 FDA 483 AIRGAS USA, LLC - Form 483, 2015-01-14
September, 2014 FDA 483 Innoteq, Inc. - Form 483, 2014-09-25
April, 2012 FDA 483 Sheffield Pharmaceuticals LLC - Form 483, 2012-04-13
February, 2015 FDA 483 Alexion Pharma LLC - Form 483, 2015-02-19
January, 2011 FDA 483 Unilever HPC - Form 483, 2011-01-14
February, 2012 FDA 483 Pfizer Laboratories Div Pfizer Inc - Form 483, 2012-02-24
May, 2015 EIR Greenfield Global USA Inc - EIR, 2015-05-21

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more